SREC-Ⅰ在烟曲霉菌性角膜炎天然免疫中的作用
该研究在体外和体内(小鼠模型)探讨清道夫受体SREC-Ⅰ在烟曲霉菌性角膜炎中的作用。烟曲霉菌刺激可上调人角膜上皮细胞中SREC-Ⅰ的表达,SREC-Ⅰ小干扰RNA能抑制LOX-1、IL-1β和TNF-α的表达。在小鼠真菌性角膜炎模型中,抗SREC-Ⅰ中和抗体治疗可降低CLCX1、LOX-1、IL-1β和TNF-α的表达。结论认为SREC-Ⅰ是烟曲霉菌性角膜炎炎症反应的关键介质,阻断SREC-Ⅰ可能是潜在的治疗方法。
要点
- 烟曲霉菌刺激可显著上调人角膜上皮细胞中SREC-Ⅰ mRNA和蛋白水平。
- SREC-Ⅰ小干扰RNA处理可抑制人角膜上皮细胞中LOX-1、IL-1β和TNF-α的表达。
- 抗SREC-Ⅰ中和抗体可降低小鼠真菌性角膜炎中CLCX1、LOX-1、IL-1β和TNF-α的表达。
核心结论
- SREC-Ⅰ是烟曲霉菌性角膜炎诱导的炎症反应的关键介质。
- 阻断SREC-Ⅰ可能是真菌性角膜炎的潜在治疗方法。
研究设计与样本
- 体外实验使用正常和烟曲霉菌刺激的人角膜上皮细胞(HCECs)。
- 免疫荧光检测人角膜中SREC-Ⅰ表达(有或无烟曲霉菌感染)。
- HCECs经SREC-Ⅰ小干扰RNA处理后,检测烟曲霉菌刺激后LOX-1、IL-1β和TNF-α mRNA水平。
- 建立小鼠真菌性角膜炎模型,用RT-PCR、Western blot和免疫荧光检测SREC-Ⅰ表达,临床评分评估严重程度。
- 检测抗SREC-Ⅰ治疗前后CLCX1、LOX-1、IL-1β和TNF-α mRNA表达水平。
主要发现
- SREC-Ⅰ表达于正常和烟曲霉菌处理的人角膜上皮细胞及人角膜上皮。
- 体外实验显示烟曲霉菌刺激后SREC-Ⅰ mRNA和蛋白水平显著增加。
- SREC-Ⅰ小干扰RNA处理抑制HCECs中LOX-1、IL-1β和TNF-α的表达。
- 小鼠烟曲霉菌性角膜炎中CLCX1、LOX-1、IL-1β和TNF-α表达升高,抗SREC-Ⅰ中和抗体治疗可降低这些表达。
临床怎么用
- SREC-Ⅰ blockade可能作为真菌性角膜炎的潜在治疗策略,但尚需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the role of scavenger receptor expressed by endothelial cell-1 (SREC-Ⅰ) in vitro and in a mouse model of Aspergillus fumigatus keratitis. METHODS: SREC-Ⅰ mRNA and protein expression were tested in both normal and A fumigatus stimulated human corneal epithelial cells (HCECs). Immunofluorescence was used to detect SREC-Ⅰ expression in human corneas with or without A fumigatus infection. HCECs were incubated with SREC-Ⅰ small interfering RNA, then the mRNA levels of LOX-1, IL-1β, and TNF-α were detected after A fumigatus stimulation. A mouse fungal keratitis (FK) model was established and SREC-Ⅰ mRNA and protein expression were detected by RT-PCR, Western blot and immunofluorescence. The severity of FK was evaluated by clinical score. CLCX1, LOX-1, IL-1β, and TNF-α mRNA expression levels were tested before and after anti-SREC-Ⅰ treatment. RESULTS: SREC-Ⅰ expressed in normal and A fumigatus treated HCECs and human corneal epithelium. In vitro experiment showed that SREC-Ⅰ mRNA and protein levels were significantly increased after A fumigatus stimulation. SREC-Ⅰ small interfering RNA treatment inhibited the expressions of LOX-1, IL-1β, and TNF-α in HCECs. The expressions of CLCX1, LOX-1, IL-1β, and TNF-α were elevated in mice with A fumigatus keratitis, which could be decreased by SREC-Ⅰ-neutralizing antibody treatment. CONCLUSIONS: SREC-Ⅰ is a key mediator in inflammatory response induced by A fumigatus keratitis. SREC-Ⅰ blockade could be a potential therapeutic approach for FK.
引用
- Zhang R, Peng X, Lin J, et al. The Role of SREC-Ⅰ in Innate Immunity to Aspergillus fumigatus Keratitis. Invest Ophthalmol Vis Sci. 2021. PMID: 34236384. doi:10.1167/iovs.62.9.12
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。